Predict your next investment

Corporation
medeonbio.com

See what CB Insights has to offer

Investments

2

Partners & Customers

2

About Medeon Biodesign

Medeon Biodesign (TPEx: 6499) is a publicly traded company located in Taipei, Taiwan, and currently listed on Taipei Exchange. The company focuses on the development of medical devices for minimally invasive surgeries to treat diseases of sizable patient population, such as cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, gynecology, urology, and plastic surgery.

Medeon Biodesign Headquarter Location

7F, 116, HouGang Street

Taipei, 11170,

Taiwan

+886 2 2881 6686

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Medeon Biodesign

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Medeon Biodesign in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Latest Medeon Biodesign News

MediBalloon Expands Operations And Establishes Mass Production Capabilities In Taiwan's Medeologix

Jan 3, 2022

MediBalloon Expands Operations And Establishes Mass Production Capabilities In Taiwan's Medeologix HAYWARD, Calif., Jan. HAYWARD, Calif., Jan. 3, 2022 /PRNewswire/ -- MediBalloon, Inc., a specialty medical balloon design and manufacturing company, today announced the partnership with Medeon Biodesign, Inc. (TPEX: 6499), a Taiwan publicly traded medical device company with operations in Taipei, Taiwan and Sunnyvale, California, to expand the US operations and footprint in Asia. The new manufacturing organization established in Taiwan will be called Medeologix and will be in full operation in 2022 to not only serve the global market, but also provide customers the one-stop-shop service from prototyping to mass production of medical devices. MediBalloon, with over 25 years of medical device industry experience, is specialized in specialty medical balloons across a wide range of clinical applications including cardiovascular, neurovascular, structural heart, peripheral, general surgery and urology. The team is experienced in handling advanced materials to design medical balloons with a spectrum of compliance, size, shape, complexity and composite construction. MediBalloon provides the most comprehensive services in the industry for this critical component from design and development, assembly process, coating, to manufacturing and mass production of specialty medical balloons. Mr. Anant Hegde, the founder and CTO of MediBalloon, and board member of Medeologix stated, "Our goal has been to provide our customers the ultimate solution when developing medical balloon products. We provide short turnaround time during the design and development phase, and now we will be equipped with a state-of-the-art facility and multiple production lines, which significantly boosts our capacity to meet the growing demand of mass production for our global customers. The partnership between MediBalloon and Medeon Biodesign benefits from the efficiency and manufacturing capabilities of Taiwan, with a highly educated and talented workforce, which will allow us to extend the top-notch medical balloon development know-how to mass production." "We are very excited to partner with MediBalloon to establish the most premier medical balloon manufacturing organization. We envision the partnership to provide cutting-edge, high quality medical products to the globe, with more efficient and effective operations." said Dr. Yue- Teh Jang, Chairman and CEO of Medeon Biodesign. About MediBalloon MediBalloon is a privately held company based in Hayward, California. The company specialized in developing medical balloons across a wide range of clinical applications using Silicone, Polyurethane, Polyethylene, Polyvinylidene fluoride (PVDF), Polybutylene terephthalate (PBT), Polyethylene terephthalate (PET), PEBAX, Nylons and other thermoplastic elastomers (TPEs), etc. For more information, please visit www.mediballoon.com . About Medeon Biodesign Medeon Biodesign (TPEX: 6499) is a publicly traded company listed on Taipei Exchange, headquartered in Taipei, Taiwan with operation in Sunnyvale, California. The company focuses on the development of medical devices and supplying key injection molded components to the medical device industry through its Delta Asia subsidiary. For more information, please visit www.medeonbio.com/en . View original content: https://www.prnewswire.com/news-releases/mediballoon-expands-operations-and-establishes-mass-production-capabilities-in-taiwans-medeologix-301452654.html

Medeon Biodesign Investments

2 Investments

Medeon Biodesign has made 2 investments. Their latest investment was in Prodeon as part of their Corporate Minority on July 7, 2019.

CBI Logo

Medeon Biodesign Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/8/2019

Corporate Minority

Prodeon

Yes

2

3/28/2017

Series A

Subscribe to see more

Subscribe to see more

10

Date

7/8/2019

3/28/2017

Round

Corporate Minority

Series A

Company

Prodeon

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Co-Investors

Sources

2

10

Medeon Biodesign Partners & Customers

2 Partners and customers

Medeon Biodesign has 2 strategic partners and customers. Medeon Biodesign recently partnered with mediballoon on January 1, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

1/3/2022

Partner

investors-news-and-events – Medeon MediBalloon Expands Operations and Establishes Mass Production Capabilities in Taiwan’s Medeologix.

The partnership between MediBalloon and Medeon Biodesign , Inc. benefits from the efficiency and manufacturing capabilities of Taiwan , with a highly educated and talented workforce , which will allow us to extend the top-notch medical balloon development know-how to mass production . ''

1

1/3/2022

Partner

Subscribe to see more

Subscribe to see more

10

Date

1/3/2022

1/3/2022

Type

Partner

Partner

Business Partner

Country

News Snippet

investors-news-and-events – Medeon MediBalloon Expands Operations and Establishes Mass Production Capabilities in Taiwan’s Medeologix.

The partnership between MediBalloon and Medeon Biodesign , Inc. benefits from the efficiency and manufacturing capabilities of Taiwan , with a highly educated and talented workforce , which will allow us to extend the top-notch medical balloon development know-how to mass production . ''

Subscribe to see more

Subscribe to see more

Sources

1

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.